These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 1725034

  • 1. Efficacy and safety of ramipril in combination with hydrochlorothiazide: results of a long-term study.
    Heidbreder D, Froer KL, Bauer B, Cairns V, Breitstadt A.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S169-73. PubMed ID: 1725034
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive efficacy, tolerance, and safety of long-term treatment with ramipril in patients with mild-to-moderate essential hypertension.
    Schreiner M, Berendes B, Verho M, Langley A, Cairns V.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S137-40. PubMed ID: 1725024
    [Abstract] [Full Text] [Related]

  • 3. An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertension.
    Bauer B, Lorenz H, Zahlten R.
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S70-4. PubMed ID: 2474109
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
    Oigman W, Gomes MA, Pereira-Barretto AC, Póvoa R, Kohlmann O, Rocha JC, Nobre F.
    Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
    [Abstract] [Full Text] [Related]

  • 5. Assessment of the efficacy, tolerance, and safety of ramipril in diabetic patients with mild-to-moderate hypertension: a retrospective analysis.
    Erhard W, Lindner U, Krall H, Breitstadt A, Pfeiffer C.
    J Cardiovasc Pharmacol; 1991 May; 18 Suppl 2():S160-4. PubMed ID: 1725032
    [Abstract] [Full Text] [Related]

  • 6. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 7. Dose-response relationship of ramipril in patients with mild-to-moderate hypertension.
    Schnaper HW.
    J Cardiovasc Pharmacol; 1991 Sep; 18 Suppl 2():S128-30. PubMed ID: 1725021
    [Abstract] [Full Text] [Related]

  • 8. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 9. The effect of ramipril on ambulatory blood pressure: a multicenter trial.
    Burris JF.
    J Cardiovasc Pharmacol; 1991 Jan; 18 Suppl 2():S131-3. PubMed ID: 1725022
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive efficacy, tolerance, and safety of ramipril in young vs. old patients: a retrospective study.
    Saalbach R, Wochnik G, Mauersberger H, Cairns V, Breitstadt A, Rangoonwala B.
    J Cardiovasc Pharmacol; 1991 Jan; 18 Suppl 2():S134-6. PubMed ID: 1725023
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 12. Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension.
    White WB, Stimpel M.
    J Hum Hypertens; 1995 Nov; 9(11):879-84. PubMed ID: 8583466
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
    Mroczek WJ.
    J Cardiovasc Pharmacol; 1991 Nov; 18 Suppl 2():S147-9. PubMed ID: 1725028
    [Abstract] [Full Text] [Related]

  • 14. Comparison of response rates to the angiotensin-converting enzyme inhibitor ramipril in mild-to-moderate hypertension in a double-blind, parallel-group study and an open single-blind study.
    Vasmant D, Lendresse P, Lemarie JC, Gallet M.
    J Cardiovasc Pharmacol; 1991 Nov; 18 Suppl 2():S144-6. PubMed ID: 1725027
    [Abstract] [Full Text] [Related]

  • 15. Tolerability of ramipril in a multicenter study of mild-to-moderate hypertension in general practice.
    Carré A, Vasmant D, Elmalem J, Thiéry P.
    J Cardiovasc Pharmacol; 1991 Nov; 18 Suppl 2():S141-3. PubMed ID: 1725026
    [Abstract] [Full Text] [Related]

  • 16. The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.
    Fox JC, Leight K, Sutradhar SC, Demopoulos LA, Gleim GW, Lewin AJ, Bakris GL.
    J Clin Hypertens (Greenwich); 2004 Aug; 6(8):437-42; quiz 443-4. PubMed ID: 15308882
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 18. Comparison of ramipril against atenolol in controlling mild-to-moderate hypertension.
    Lenox-Smith AJ, Street RB, Kendall FD.
    J Cardiovasc Pharmacol; 1991 Sep; 18 Suppl 2():S150-2. PubMed ID: 1725029
    [Abstract] [Full Text] [Related]

  • 19. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
    White WB, Cleveland JM, Rolleri RL, Ramipril-Hydrochlorothiazide Study Group.
    J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
    [Abstract] [Full Text] [Related]

  • 20. Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension.
    Witte PU, Walter U.
    Am J Cardiol; 1987 Apr 24; 59(10):115D-120D. PubMed ID: 3034018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.